Nom du produit:2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetic acid

IUPAC Name:2-{4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-[4-methoxy-2-(propan-2-yloxy)phenyl]-4,5-dihydro-1H-imidazole-1-carbonyl]-2-oxopiperazin-1-yl}acetic acid

CAS:2306390-08-7
Formule moléculaire:C32H32Cl2N4O6
Pureté:95%+
Numéro de catalogue:CM340805
Poids moléculaire:639.53

Unité d'emballage Stock disponible Prix($) Quantité
CM340805-50mg in stock IJǙƿ
CM340805-100mg in stock ƥIJIJ
CM340805-250mg in stock ǪǙƿǪ
CM340805-1g in stock ľȃŗƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2306390-08-7
Formule moléculaire:C32H32Cl2N4O6
Point de fusion:-
Code SMILES:O=C(O)CN1C(CN(C(N2[C@@H](C3=CC=C(Cl)C=C3)[C@@H](C4=CC=C(Cl)C=C4)N=C2C5=CC=C(OC)C=C5OC(C)C)=O)CC1)=O
Densité:
Numéro de catalogue:CM340805
Poids moléculaire:639.53
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.